Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
Fountzilas G, Polichronis A, Katsohis K, Gennatas K, Toussis D, Skarlos D, Kosmidis P, Vassilaros S, Semoglou C, Giannakakis T, Fahantidis E, Klouvas G, Tsavaris N, Konstantaras C, Makrantonakis P, Kolotas C, Zamboglou N, Tsiliakos S, Hainoglou D, Mylonakis N, Pavlidis N.
Fountzilas G, et al.
Oncology. 1996 Mar-Apr;53(2):137-46. doi: 10.1159/000227550.
Oncology. 1996.
PMID: 8604240
Clinical Trial.